SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Trading Update

26 Apr 2019 07:00

RNS Number : 1677X
Rotork PLC
26 April 2019
 

Rotork Plc

Trading update

Rotork plc ("Rotork"), the global flow control and instrumentation company, issues the following trading update covering the first quarter period from 1 January to 31 March 2019 ahead of its Annual General Meeting to be held today.

The first quarter saw a gradual improvement in overall levels of activity from the fourth quarter. Order intake (on an organic constant currency basis, "OCC") was modestly ahead of the fourth quarter, though as anticipated was down on the 2018 comparator period which included several large greenfield orders, principally from the Downstream Oil & Gas end user market. 

Our Growth Acceleration Programme continues on track with progress across all four pillars. Our lean/continuous improvement rollout has started encouragingly. Our phased transition to a market segment orientation commences in the second quarter with China, Japan and South Korea. 

Rotork continues to be highly cash generative with a strong balance sheet and net cash of £46.5m at 31 March 2019 (£43.6m at 31 December 2018).

Whilst we remain mindful of macroeconomic uncertainty we continue to expect to deliver modest sales growth on an OCC basis in 2019, with lower year on year sales in the first half reflecting the strong comparator period, and full year margins to show progress on 2018.

Rotork will publish 2019 half-year results on Tuesday 6 August 2019.

 

Enquiries:

Rotork plc Tel: +44 (0)1225 733 200

Kevin Hostetler, Chief Executive

Jonathan Davis, Finance Director

Andrew Carter, Investor Relations Director

 

FTI Consulting Tel: + 44 (0)20 3727 1340

Nick Hasell / Susanne Yule

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The figures quoted in this announcement are unaudited and are subject to the review process that will be undertaken for the H1 19 results announcement. The person responsible for arranging for the release of this announcement on behalf of Rotork is Helen Barrett-Hague (Company Secretary).

 

Notes

1. OCC (organic constant currency) growth rates restate 2019 at 2018 exchange rates and remove the contributions from disposals made in 2018.

2. This announcement contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement, and Rotork undertakes no obligation to update these forward-looking statements. Nothing in this Trading Statement should be construed as a profit forecast.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFVTSVIEFIA
Date   Source Headline
12th Mar 202510:49 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNS2024 full year results
11th Mar 20257:00 amRNSShare buyback programme
11th Mar 20257:00 amRNSAcquisition of Noah Actuation
7th Mar 20251:35 pmRNSHolding(s) in Company
3rd Mar 20259:02 amRNSTotal Voting Rights
11th Feb 20254:15 pmRNSDirector/PDMR Shareholding
3rd Feb 20259:45 amRNSTotal Voting Rights
13th Jan 20254:18 pmRNSDirector/PDMR Shareholding
2nd Jan 20259:43 amRNSTotal Voting Rights
16th Dec 20243:34 pmRNSDirector/PDMR Shareholding
11th Dec 20244:40 pmRNSDirector/PDMR Shareholding
9th Dec 20241:20 pmRNSCompletion of Share Buyback Programme
6th Dec 20245:43 pmRNSTransaction in Own Shares
5th Dec 20245:15 pmRNSTransaction in Own Shares
4th Dec 20245:19 pmRNSTransaction in Own Shares
3rd Dec 20245:10 pmRNSTransaction in Own Shares
3rd Dec 202411:50 amRNSBoard Committee and Board Role Changes
2nd Dec 20245:12 pmRNSTransaction in Own Shares
2nd Dec 20249:27 amRNSTotal Voting Rights
29th Nov 20245:38 pmRNSTransaction in Own Shares
28th Nov 20245:20 pmRNSTransaction in Own Shares
27th Nov 20245:40 pmRNSTransaction in Own Shares
26th Nov 20245:25 pmRNSTransaction in Own Shares
25th Nov 20245:14 pmRNSTransaction in Own Shares
22nd Nov 20245:17 pmRNSTransaction in Own Shares
21st Nov 20245:04 pmRNSTransaction in Own Shares
20th Nov 20245:09 pmRNSTransaction in Own Shares
20th Nov 202411:00 amRNSDirectorate Change
20th Nov 20247:00 amRNSTrading Update
19th Nov 20245:07 pmRNSTransaction in Own Shares
18th Nov 20245:21 pmRNSTransaction in Own Shares
15th Nov 20245:11 pmRNSTransaction in Own Shares
14th Nov 20245:15 pmRNSTransaction in Own Shares
13th Nov 20245:16 pmRNSTransaction in Own Shares
12th Nov 20245:33 pmRNSTransaction in Own Shares
12th Nov 202412:44 pmRNSDirector/PDMR Shareholding
11th Nov 20245:08 pmRNSTransaction in Own Shares
8th Nov 20245:22 pmRNSTransaction in Own Shares
7th Nov 20245:12 pmRNSTransaction in Own Shares
7th Nov 202412:21 pmRNSShare Buy-Back Programme
1st Nov 20249:17 amRNSTotal Voting Rights
25th Oct 20245:36 pmRNSTransaction in Own Shares
24th Oct 20245:10 pmRNSTransaction in Own Shares
23rd Oct 20245:07 pmRNSTransaction in Own Shares
22nd Oct 20245:09 pmRNSTransaction in Own Shares
21st Oct 20244:53 pmRNSTransaction in Own Shares
18th Oct 20244:54 pmRNSTransaction in Own Shares
17th Oct 20245:07 pmRNSTransaction in Own Shares
16th Oct 20245:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.